세계의 포스콜린 시장 규모 : 농도별, 용도별, 최종 용도별 예측(2024-2032년)

The Forskolin Market will record over 8% CAGR during 2024-2032, driven by the increasing prevalence of cardiovascular diseases and respiratory disorders. According to the American College of Cardiology, the global death toll from cardiovascular diseases (CVD) has surged, rising from 12.4 million in 1990 to 19.8 million in 2022.

Forskolin is recognized for its potential therapeutic benefits, including its ability to relax smooth muscles and improve heart function. With the rising incidence of heart ailments and breathing disorders globally, there is a heightened demand for natural and effective remedies. Forskolin's role in improving cardiovascular health and alleviating respiratory issues has positioned it as a key component in pharmaceutical products. This factor, along with consumer preference for natural and holistic health solutions is pushing the market growth.

Further, forskolin, with its anti-inflammatory and antioxidant properties, is gaining popularity as a valuable ingredient in skincare formulations. The rising popularity of herbal and organic skincare products is significantly adding to the demand.

The forskolin industry is classified based on concentration, application, end-use, and region.

The medium concentration (20%-40%) segment will witness robust growth through 2032, due to its balanced efficacy and safety profile. This concentration range is considered optimal for achieving desired health benefits without causing adverse effects. The medium concentration forskolin variant is extensively used in weight management, cardiovascular health supplements, and energy-boosting formulations. The increasing consumer inclination towards preventive healthcare and the rising popularity of natural supplements are key factors contributing to the growth of this segment.

The dermatology segment will create substantial demand for forskolin by 2032, driven by its anti-inflammatory and antioxidant properties. Forskolin is incorporated into skincare and dermatological products to address various skin conditions such as eczema, psoriasis, and acne. Its ability to promote cyclic AMP levels enhances skin cell function and repair, making it a valuable ingredient in anti-aging and skin-rejuvenation products. Moreover, its natural origin and minimal side effects make it an attractive alternative to synthetic compounds in the cosmetic and dermatology industries.

Europe forskolin industry size is anticipated to expand at a rapid pace through 2032, with countries like Germany, France, and the United Kingdom leading the demand. The region's stringent regulations favoring natural and organic products have bolstered the adoption of forskolin in various industries. The growing trend of natural health supplements and the increasing popularity of herbal skincare products have significantly contributed to the market growth in Europe. Additionally, the presence of well-established cosmetic and pharmaceutical industries in the region provides a strong platform for the expansion of Forskolin-based products.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Value chain
  • 3.1.2 Key manufacturers
  • 3.1.3 Go to market routes
  • 3.1.4 Key distributors
    • 3.1.4.1 New distribution channels
  • 3.1.5 Profit margins across the industry
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Market challenges
  • 3.2.3 Market opportunities
    • 3.2.3.1 New markets/applications
    • 3.2.3.2 Growth potential analysis
• 3.3 Raw material landscape
  • 3.3.1 Manufacturing trends
    • 3.3.1.1 Technology evolution
    • 3.3.1.2 Sustainable manufacturing
      • 3.3.1.2.1 Green practices
      • 3.3.1.2.2 Decarbonization
  • 3.3.2 New raw materials
  • 3.3.3 Pricing trends (USD/Ton)
    • 3.3.3.1 North America
    • 3.3.3.2 Europe
    • 3.3.3.3 Asia Pacific
    • 3.3.3.4 Latin America
    • 3.3.3.5 Middle East & Africa
• 3.4 Regulations & market impact
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Concentrated Type, 2021-2032 (USD Million, Tons)

• 5.1 Key trends
• 5.2 Low concentration {10%}
• 5.3 Medium concentration {20%-40%}
• 5.4 High concentration {95%}

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

• 6.1 Key trends
• 6.2 Allergy treatment
• 6.3 Weight management
• 6.4 Respiratory problems
• 6.5 Dermatology
• 6.6 Others

Chapter 7 Market Size and Forecast, By End User, 2021-2032 (USD Million, Tons)

• 7.1 Key trends
• 7.2 Pharmaceuticals
• 7.3 Nutraceuticals
• 7.4 Cosmetics and personal care
• 7.5 Dietary supplement
• 7.6 Others

Chapter 8 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 MEA
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 South Africa
  • 8.6.4 Rest of MEA

Chapter 9 Company Profiles

• 9.1 BioGanix
• 9.2 ChromaDex Corp.
• 9.3 Herbal Nutrition LLC
• 9.4 Himalaya Wellness
• 9.5 Indena S.p.A.
• 9.6 Life Extension
• 9.7 Nature's Way Products, LLC
• 9.8 NutraBio Labs, Inc.
• 9.9 NUTRALIE
• 9.10 Sabinsa Corporation
• 9.11 Sabinsa Europe GmbH
• 9.12 Swanson Health Products, Inc.